Scale by Design - Venture Capital Show

S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber

December 15, 2022 SecureVision Season 2 Episode 4
Scale by Design - Venture Capital Show
S2 E4: Synthetic biology’s potential to change the world. How the shortfall of semi-commercial fermentation capacity is stunting development of new products w Jason Webber
Show Notes

Jason Webber, Principal and Co-Founder at Sustainable Conversion Ventures joins host James Mackey on Scale by Design - Venture Capital Show.

Jason Webber explains how many great innovations will die on the vine with the growing shortfall of semi-commercial fermentation capacity. Not necessarily capacity for the multi-billion dollar markets (food/proteins) so much as those getting squeezed out in the sub-billion dollar markets that could be most disruptive. These are typically too small for strategics to care about but ripe for innovation due to stagnation.

Our host James Mackey, SecureVision CEO

Listen to our full episode list here:
https://www.scalebydesign.io/

Follow us:
https://www.linkedin.com/company/scalebydesign/

Our YouTube channel:
https://www.youtube.com/@securevision1677

#1 Rated Embedded Recruitment Firm on G2!
https://www.g2.com/products/securevision/reviews

Thanks for listening!